Peter Sasieni
Overview
Explore the profile of Peter Sasieni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
182
Citations
5350
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cumberbatch M, North B, Kealy R, Smith S, Hubbard R, Kennish S, et al.
BMJ Open
. 2025 Feb;
15(2):e096431.
PMID: 39933820
Background: Prostate cancer (PCa) is the most common male malignancy in the western world. Many men (40%) are diagnosed with localised low or intermediate-risk PCa, which is suitable for active...
2.
Swanton C, Bachtiar V, Mathews C, Brentnall A, Lowenhoff I, Waller J, et al.
Clin Trials
. 2025 Jan;
17407745241302477.
PMID: 39862108
Background/aims: Certain sociodemographic groups are routinely underrepresented in clinical trials, limiting generalisability. Here, we describe the extent to which enriched enrolment approaches yielded a diverse trial population enriched for older...
3.
Kocher H, Sasieni P, Corrie P, McNamara M, Sarker D, Froeling F, et al.
BMC Cancer
. 2025 Jan;
25(1):106.
PMID: 39833722
Background: Pancreatic cancer (PDAC: pancreatic ductal adenocarcinoma, the commonest form), a lethal disease, is best treated with surgical excision but is feasible in less than a fifth of patients. Around...
4.
Falcaro M, Castanon A, Ndlela B, Sasieni P
Lancet Reg Health Eur
. 2025 Jan;
49:101157.
PMID: 39759575
Background: Monitoring trends in diseases after the implementation of new public health interventions or policy changes is crucial for public health planning and surveillance. In this study we look at...
5.
Lei J, Cuschieri K, Patel H, Lawrence A, Deats K, Sasieni P, et al.
PLoS Med
. 2024 Dec;
21(12):e1004494.
PMID: 39666756
Background: Human papillomavirus (HPV) testing of self-collected vaginal samples has potential to improve coverage of cervical screening programmes, but current guidelines mostly require those HPV positive on a self-sample to...
6.
Sasieni P, Smittenaar R, Hubbell E, Broggio J, Neal R, Swanton C
Br J Cancer
. 2024 Nov;
131(12):1942-1944.
PMID: 39558064
No abstract available.
7.
8.
Sasieni P, Brentnall A
J Natl Cancer Inst
. 2024 Oct;
117(3):450-455.
PMID: 39400565
Background: The NHS-Galleri Trial has demonstrated feasibility of a trial design in which all participants provide a "sample" for screening, but only samples from the intervention arm are tested and...
9.
Dull P, Achilles S, Ahmed R, Barnabas R, Campos N, Chirgwin K, et al.
Vaccine
. 2024 Jul;
42(25):126100.
PMID: 39004526
Cervical cancer is a major cause of morbidity and mortality globally with a disproportionate impact on women in low- and middle-income countries. In 2021, the World Health Organization (WHO) called...
10.
Tan W, Ahmad A, Zhou Y, Nathan A, Ogunbo A, Gbolahan O, et al.
Eur Urol Oncol
. 2024 May;
8(1):87-93.
PMID: 38811250
Background: Hematuria is a cardinal symptom of urinary tract cancer and would require further investigations. Objective: To determine the ability of renal bladder ultrasound (RBUS) with the Hematuria Cancer Risk...